Lifeway Foods (LWAY) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
1 Feb, 2026Executive summary
Achieved record net sales of $49.2 million for Q2 2024, up 25.3% year-over-year, marking the fifth consecutive quarterly sales record and 19th consecutive quarter of growth.
Net sales for the first half of 2024 reached $93.8 million, a 21.6% increase compared to the same period in 2023.
Growth driven primarily by increased volume of flagship drinkable kefir products and effective marketing investments.
Net income for Q2 2024 was $3.8 million, up from $3.2 million in Q2 2023, with EPS of $0.26 basic and $0.25 diluted.
Strong business momentum and loyal customer base position the company for another record year.
Financial highlights
Gross profit margin for Q2 2024 was 27.0%, improving sequentially but down from 28.7% in Q2 2023 due to unfavorable milk pricing.
Operating income for Q2 2024 was $5.4 million, up from $4.8 million a year ago.
Selling, general, and administrative expenses were $7.8 million for Q2 2024, representing 15.8% of net sales.
Cash flow from operations for the first half of 2024 was $8.1 million, up from $5.5 million in the prior year.
Capital spending increased to $3.9 million for the first half of 2024, focused on growth, cost reduction, and facility improvements.
Outlook and guidance
On pace to set another annual sales record in 2024, with continued strong growth expected in the back half of the year.
Confident in ability to maintain sales momentum and further improve margins through operational efficiencies.
Management expects moderate inflationary pressures in 2024 and continued ability to meet customer demand.
Sufficient liquidity is anticipated through cash flow, credit facilities, and cash on hand for ongoing operations and growth initiatives.
Plans to continue strategic investments in the brand to drive product velocities, acquire new customers, and sustain growth.
Latest events from Lifeway Foods
- Q3 2024 sales up 12.7%, net income $3M, global expansion, and Danone bid rejected.LWAY
Q3 202414 Jan 2026 - ISS backs the full board slate for the 2025 meeting, urging shareholders to vote accordingly.LWAY
Proxy Filing19 Dec 2025 - Up to 3.45 million shares are being resold by a major shareholder as part of a governance agreement.LWAY
Registration Filing16 Dec 2025 - Board refreshes with independent directors, urges rejection of dissident nominees amid strong results.LWAY
Proxy Filing11 Dec 2025 - Proxy contest targets board overhaul, new oversight committee, and governance reforms.LWAY
Proxy Filing5 Dec 2025 - Board urges rejection of dissident nominees amid strong performance and governance refresh.LWAY
Proxy Filing2 Dec 2025 - Shareholders are solicited to replace the board, restore bylaws, and ban nepotism amid governance concerns.LWAY
Proxy Filing2 Dec 2025 - Proxy contest aims to replace board over independence concerns and strategic direction.LWAY
Proxy Filing2 Dec 2025 - Shareholders are solicited to overhaul the board, restore bylaws, and ban nepotism for better governance.LWAY
Proxy Filing2 Dec 2025